Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amitriptyline for Post-Traumatic Headache Prevention
NCT01856270Phase 2Completed
- Sponsor
- University of Washington
- Start
- Apr 2013
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of amitriptyline in post-traumatic headache (PTH) (2 arms), sponsored by University of Washington. Primary endpoints: Frequency of Headaches at 90 days and Severity of Headache at 90 days. Started Apr 2013; status: completed.
02
Drugs
amitriptyline
03
Conditions
post-traumatic headache (PTH)
Beyond the preview
Go deeper on NCT01856270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01856270.